Celecoxib is a selective COX-2 inhibitor (non-steroidal anti-inflammatory drug, NSAID) used to reduce inflammation while minimizing gastrointestinal irritation compared with many traditional NSAIDs. In selected patients, it may help control persistent inflammatory processes and improve overall treatment tolerance when used as part of a physician-directed therapeutic plan.

Within Autism Navigator treatment protocols, celecoxib may be prescribed to support the management of chronic systemic and neuroinflammation when clinically indicated. Treatment decisions, dosing schedules, and duration of therapy should always be individualized and determined by a qualified healthcare professional.